150 related articles for article (PubMed ID: 38396325)
1. IL-8 from CD248-expressing cancer-associated fibroblasts generates cisplatin resistance in non-small cell lung cancer.
Wu J; Zhang Q; Wu J; Yang Z; Liu X; Lou C; Wang X; Peng J; Zhang J; Shang Z; Xiao J; Wang N; Zhang R; Zhou J; Wang Y; Hu Z; Zhang R; Zhang J; Zeng Z
J Cell Mol Med; 2024 Feb; 28(4):e18185. PubMed ID: 38396325
[TBL] [Abstract][Full Text] [Related]
2. CAFs-Derived Exosomal miRNA-130a Confers Cisplatin Resistance of NSCLC Cells Through PUM2-Dependent Packaging.
Zhang T; Zhang P; Li HX
Int J Nanomedicine; 2021; 16():561-577. PubMed ID: 33542625
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG12 in extracellular vesicles derived from carcinoma-associated fibroblasts promotes cisplatin resistance in non-small cell lung cancer cells.
Tan D; Li G; Zhang P; Peng C; He B
Bioengineered; 2022 Jan; 13(1):1838-1857. PubMed ID: 35014944
[TBL] [Abstract][Full Text] [Related]
4. CHD1L contributes to cisplatin resistance by upregulating the ABCB1-NF-κB axis in human non-small-cell lung cancer.
Li Y; He LR; Gao Y; Zhou NN; Liu Y; Zhou XK; Liu JF; Guan XY; Ma NF; Xie D
Cell Death Dis; 2019 Feb; 10(2):99. PubMed ID: 30718500
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-induced PDL-1 expression in cancer-associated fibroblasts promotes chemoresistance in NSCLC.
Heenatigala Palliyage G; Samart P; Bobbala S; Rojanasakul LW; Coyle J; Martin K; Callery PS; Rojanasakul Y
Lung Cancer; 2023 Jul; 181():107258. PubMed ID: 37245409
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer.
Zhai J; Shen J; Xie G; Wu J; He M; Gao L; Zhang Y; Yao X; Shen L
Cancer Lett; 2019 Jul; 454():37-43. PubMed ID: 30978440
[TBL] [Abstract][Full Text] [Related]
7. CXCL12 derived from CD248-expressing cancer-associated fibroblasts mediates M2-polarized macrophages to promote nonsmall cell lung cancer progression.
Wu J; Liu X; Wu J; Lou C; Zhang Q; Chen H; Yang Z; Long S; Wang Y; Shang Z; Hu Z; Zhang R; Zhang J; Zeng Z
Biochim Biophys Acta Mol Basis Dis; 2022 Nov; 1868(11):166521. PubMed ID: 35985448
[TBL] [Abstract][Full Text] [Related]
8. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
Gao J; Meng Q; Zhao Y; Chen X; Cai L
BMC Cancer; 2016 Jul; 16():470. PubMed ID: 27411790
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblasts secreted miR-103a-3p suppresses apoptosis and promotes cisplatin resistance in non-small cell lung cancer.
Wang H; Huang H; Wang L; Liu Y; Wang M; Zhao S; Lu G; Kang X
Aging (Albany NY); 2021 May; 13(10):14456-14468. PubMed ID: 33999859
[TBL] [Abstract][Full Text] [Related]
11. microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling.
Huang RS; Zheng YL; Zhao J; Chun X
Biomed Pharmacother; 2018 Feb; 98():538-544. PubMed ID: 29287202
[TBL] [Abstract][Full Text] [Related]
12. Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo.
Jafri SH; Glass J; Shi R; Zhang S; Prince M; Kleiner-Hancock H
J Exp Clin Cancer Res; 2010 Jul; 29(1):87. PubMed ID: 20594324
[TBL] [Abstract][Full Text] [Related]
13. d-Borneol enhances cisplatin sensitivity via p21/p27-mediated S-phase arrest and cell apoptosis in non-small cell lung cancer cells and a murine xenograft model.
Li J; Yuan J; Li Y; Wang J; Gong D; Xie Q; Ma R; Wang J; Ren M; Lu D; Xu Z
Cell Mol Biol Lett; 2022 Jul; 27(1):61. PubMed ID: 35883026
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway.
Tao L; Huang G; Wang R; Pan Y; He Z; Chu X; Song H; Chen L
Sci Rep; 2016 Dec; 6():38408. PubMed ID: 27922075
[TBL] [Abstract][Full Text] [Related]
15. Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling.
Wang LH; Li Y; Yang SN; Wang FY; Hou Y; Cui W; Chen K; Cao Q; Wang S; Zhang TY; Wang ZZ; Xiao W; Yang JY; Wu CF
Br J Cancer; 2014 Jan; 110(2):341-52. PubMed ID: 24300974
[TBL] [Abstract][Full Text] [Related]
16. IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling.
Shintani Y; Fujiwara A; Kimura T; Kawamura T; Funaki S; Minami M; Okumura M
J Thorac Oncol; 2016 Sep; 11(9):1482-92. PubMed ID: 27287412
[TBL] [Abstract][Full Text] [Related]
17. Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells.
Quan YH; Lim JY; Choi BH; Choi Y; Choi YH; Park JH; Kim HK
Cancer Chemother Pharmacol; 2019 Mar; 83(3):399-410. PubMed ID: 30515553
[TBL] [Abstract][Full Text] [Related]
18. mir-1-mediated paracrine effect of cancer-associated fibroblasts on lung cancer cell proliferation and chemoresistance.
Li J; Guan J; Long X; Wang Y; Xiang X
Oncol Rep; 2016 Jun; 35(6):3523-31. PubMed ID: 27035564
[TBL] [Abstract][Full Text] [Related]
19. TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway.
Chen J; Gu J; Feng J; Liu Y; Xue Q; Ni T; Wang Z; Jia L; Mao G; Ji L
Tumour Biol; 2016 Mar; 37(3):3851-61. PubMed ID: 26476534
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1.
Cheng R; Lu C; Zhang G; Zhang G; Zhao G
Oncol Rep; 2017 Apr; 37(4):2129-2136. PubMed ID: 28350100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]